The use of iron oxide nanoparticles for pancreatic cancer therapy

Maryam Malekigorji, Anthony D. M. Curtis, Clare Hoskins

Research output: Contribution to journalReview article

Abstract

Over the last decade major advances have been made in the treatment of cancer such as breast and leukaemia. However, no satisfactory progress has been made in the effective treatment of pancreatic cancer. Treatment of this disease is hindered by resistance of tumor cells to chemotherapy and impaired drug delivery after administration. Pancreatic adenocarcinomas characteristically form a dense stroma, which hinders drug penetration. Increasing administration dosage may provide increased therapeutic effects. However, toxic drug molecules do not act selectively to tumor cells and, as such; a vast range of undesirable side effects can be experienced. Nano-sized formulations of cytotoxic agents have proved to passively target pancreatic adenocarcinomas and promote increased drug efficacy. This is thought to be due to the accumulation via enhanced permeability and retention resulting in deeper drug penetration. Nanoparticles with easily modified surfaces have been investigated extensively in recent years and play a pivotal role in biomedicine. In recent years, magnetic NPs have been increasingly explored for clinical applications, such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia for diagnosis and cancer therapy. In comparison with traditional cancer therapy, magnetic field operated therapeutic approaches can treat cancer in an unconventional but more effective and safer way. In this literature review, we highlight the recent advances in the use of iron oxide nanoparticles in pancreatic cancer therapy.
Original languageEnglish
Article number00004
Number of pages12
JournalJournal of Nanomedicine Research
Volume1
Issue number1
DOIs
Publication statusPublished - 1 Oct 2014

Fingerprint

Pancreatic Neoplasms
Nanoparticles
Drug delivery
Pharmaceutical Preparations
Tumors
Neoplasms
Cells
Chemotherapy
Magnetic fluids
Poisons
Magnetic Field Therapy
Cytotoxins
Adenocarcinoma
Magnetic resonance
Therapeutics
Therapeutic Uses
Magnetic fields
Imaging techniques
Molecules
ferric oxide

Keywords

  • metallic iron oxide
  • drug delivery
  • pancreatic cancer
  • magnetic resonance imaging
  • theranostic
  • cancer therapy
  • magnetic iron oxide nanoparticles

Cite this

Malekigorji, M., Curtis, A. D. M., & Hoskins, C. (2014). The use of iron oxide nanoparticles for pancreatic cancer therapy. Journal of Nanomedicine Research, 1(1), [00004]. https://doi.org/10.15406/jnmr.2014.01.00004
Malekigorji, Maryam ; Curtis, Anthony D. M. ; Hoskins, Clare. / The use of iron oxide nanoparticles for pancreatic cancer therapy. In: Journal of Nanomedicine Research. 2014 ; Vol. 1, No. 1.
@article{a33b8a9c1a3a4056964f5b0462b9d798,
title = "The use of iron oxide nanoparticles for pancreatic cancer therapy",
abstract = "Over the last decade major advances have been made in the treatment of cancer such as breast and leukaemia. However, no satisfactory progress has been made in the effective treatment of pancreatic cancer. Treatment of this disease is hindered by resistance of tumor cells to chemotherapy and impaired drug delivery after administration. Pancreatic adenocarcinomas characteristically form a dense stroma, which hinders drug penetration. Increasing administration dosage may provide increased therapeutic effects. However, toxic drug molecules do not act selectively to tumor cells and, as such; a vast range of undesirable side effects can be experienced. Nano-sized formulations of cytotoxic agents have proved to passively target pancreatic adenocarcinomas and promote increased drug efficacy. This is thought to be due to the accumulation via enhanced permeability and retention resulting in deeper drug penetration. Nanoparticles with easily modified surfaces have been investigated extensively in recent years and play a pivotal role in biomedicine. In recent years, magnetic NPs have been increasingly explored for clinical applications, such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia for diagnosis and cancer therapy. In comparison with traditional cancer therapy, magnetic field operated therapeutic approaches can treat cancer in an unconventional but more effective and safer way. In this literature review, we highlight the recent advances in the use of iron oxide nanoparticles in pancreatic cancer therapy.",
keywords = "metallic iron oxide, drug delivery, pancreatic cancer, magnetic resonance imaging, theranostic, cancer therapy, magnetic iron oxide nanoparticles",
author = "Maryam Malekigorji and Curtis, {Anthony D. M.} and Clare Hoskins",
year = "2014",
month = "10",
day = "1",
doi = "10.15406/jnmr.2014.01.00004",
language = "English",
volume = "1",
number = "1",

}

Malekigorji, M, Curtis, ADM & Hoskins, C 2014, 'The use of iron oxide nanoparticles for pancreatic cancer therapy', Journal of Nanomedicine Research, vol. 1, no. 1, 00004. https://doi.org/10.15406/jnmr.2014.01.00004

The use of iron oxide nanoparticles for pancreatic cancer therapy. / Malekigorji, Maryam ; Curtis, Anthony D. M.; Hoskins, Clare.

In: Journal of Nanomedicine Research, Vol. 1, No. 1, 00004, 01.10.2014.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The use of iron oxide nanoparticles for pancreatic cancer therapy

AU - Malekigorji, Maryam

AU - Curtis, Anthony D. M.

AU - Hoskins, Clare

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Over the last decade major advances have been made in the treatment of cancer such as breast and leukaemia. However, no satisfactory progress has been made in the effective treatment of pancreatic cancer. Treatment of this disease is hindered by resistance of tumor cells to chemotherapy and impaired drug delivery after administration. Pancreatic adenocarcinomas characteristically form a dense stroma, which hinders drug penetration. Increasing administration dosage may provide increased therapeutic effects. However, toxic drug molecules do not act selectively to tumor cells and, as such; a vast range of undesirable side effects can be experienced. Nano-sized formulations of cytotoxic agents have proved to passively target pancreatic adenocarcinomas and promote increased drug efficacy. This is thought to be due to the accumulation via enhanced permeability and retention resulting in deeper drug penetration. Nanoparticles with easily modified surfaces have been investigated extensively in recent years and play a pivotal role in biomedicine. In recent years, magnetic NPs have been increasingly explored for clinical applications, such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia for diagnosis and cancer therapy. In comparison with traditional cancer therapy, magnetic field operated therapeutic approaches can treat cancer in an unconventional but more effective and safer way. In this literature review, we highlight the recent advances in the use of iron oxide nanoparticles in pancreatic cancer therapy.

AB - Over the last decade major advances have been made in the treatment of cancer such as breast and leukaemia. However, no satisfactory progress has been made in the effective treatment of pancreatic cancer. Treatment of this disease is hindered by resistance of tumor cells to chemotherapy and impaired drug delivery after administration. Pancreatic adenocarcinomas characteristically form a dense stroma, which hinders drug penetration. Increasing administration dosage may provide increased therapeutic effects. However, toxic drug molecules do not act selectively to tumor cells and, as such; a vast range of undesirable side effects can be experienced. Nano-sized formulations of cytotoxic agents have proved to passively target pancreatic adenocarcinomas and promote increased drug efficacy. This is thought to be due to the accumulation via enhanced permeability and retention resulting in deeper drug penetration. Nanoparticles with easily modified surfaces have been investigated extensively in recent years and play a pivotal role in biomedicine. In recent years, magnetic NPs have been increasingly explored for clinical applications, such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia for diagnosis and cancer therapy. In comparison with traditional cancer therapy, magnetic field operated therapeutic approaches can treat cancer in an unconventional but more effective and safer way. In this literature review, we highlight the recent advances in the use of iron oxide nanoparticles in pancreatic cancer therapy.

KW - metallic iron oxide

KW - drug delivery

KW - pancreatic cancer

KW - magnetic resonance imaging

KW - theranostic

KW - cancer therapy

KW - magnetic iron oxide nanoparticles

U2 - 10.15406/jnmr.2014.01.00004

DO - 10.15406/jnmr.2014.01.00004

M3 - Review article

VL - 1

IS - 1

M1 - 00004

ER -

Malekigorji M, Curtis ADM, Hoskins C. The use of iron oxide nanoparticles for pancreatic cancer therapy. Journal of Nanomedicine Research. 2014 Oct 1;1(1). 00004. https://doi.org/10.15406/jnmr.2014.01.00004